Evaluation in 18 patients with polycythemia vera showed hematocrit control below 45%, accompanied by a "dramatic decrease in ...

Silence Therapeutics advanced its RNAi drug for polycythemia vera, shared new Phase 2 trial updates, and reaffirmed a strong ...

Stage 1 PV management includes phlebotomy, low-dose aspirin, cytoreductive therapy, and lifestyle changes to prevent complications. Stage 1 polycythemia vera is manageable with monitoring, phlebotomy, ...

This article was reviewed by Felix Gussone, MD. Do You Need a Prescription for Testosterone? Key Takeaways: In the U.S., ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

Injections are often less expensive, while pellets may have higher upfront costs. Dosage and frequency Higher doses or more frequent administration increase costs. Laboratory tests Blood tests to ...

A severely malnourished puppy named Sprout, who has been receiving help from the Animal Protection Center of Southeastern ...

Doctors at University Teaching Hospital of Kigali (CHUK) have successfully performed a rare Intrauterine transfusion (IUT), allowing a severely anemic fetus to survive and be delivered healthy at 36 ...

Gonzalez, S. and Almond, S. (2025) Delayed Penile Hematoma Four Weeks Post-Circumcision in an 8-Year-Old Boy: A Rare ...

“Every element of the Vivian system is being designed with safety and precision in mind,” said John Erb, Chief Executive Officer of Nuwellis. “This new patent reinforces our commitment to advancing ...

Our third quarter results reflect disciplined execution and meaningful progress toward building a more focused, U.S.-driven business,” said John Erb, Chairman and Chief Executive Officer of Nuwellis.